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Structures of EccB1 and EccD1 from the
core complex of the mycobacterial ESX-1
type VII secretion system
Jonathan M. Wagner1,4, Sum Chan2, Timothy J. Evans1,5, Sara Kahng2, Jennifer Kim2, Mark A. Arbing2,
David Eisenberg3 and Konstantin V. Korotkov1*

Abstract
Background: The ESX-1 type VII secretion system is an important determinant of virulence in pathogenic mycobacteria,
including Mycobacterium tuberculosis. This complicated molecular machine secretes folded proteins through the
mycobacterial cell envelope to subvert the host immune response. Despite its important role in disease very little
is known about the molecular architecture of the ESX-1 secretion system.
Results: This study characterizes the structures of the soluble domains of two conserved core ESX-1 components – EccB1
and EccD1. The periplasmic domain of EccB1 consists of 4 repeat domains and a central domain, which together form a
quasi 2-fold symmetrical structure. The repeat domains of EccB1 are structurally similar to a known peptidoglycan binding
protein suggesting a role in anchoring the ESX-1 system within the periplasmic space. The cytoplasmic domain of
EccD1has a ubiquitin-like fold and forms a dimer with a negatively charged groove.
Conclusions: These structures represent a major step towards resolving the molecular architecture of the entire
ESX-1 assembly and may contribute to ESX-1 targeted tuberculosis intervention strategies.
Keywords: EccB, EccD, Mycobacterium tuberculosis, Type VII secretion system, ESX

Background
Pathogenic bacteria rely on a variety of secretion systems
to transport virulence factors, proteins that mediate
host-pathogen interactions, across their hydrophobic cell
membranes to sites where they can interact with the
host. Gram-positive bacteria need only transport proteins across a single membrane, but Gram-negative bacteria require specialized secretion machinery that spans
both inner and outer membranes. Mycobacterium tuberculosis, the causative agent of tuberculosis, was recently
re-classified as a diderm bacterium when it was shown
to have an outer membrane bi-layer — referred to as the
mycomembrane — composed largely of mycolic acids
[1]. In order to transport key virulence factors across
both membranes M. tuberculosis has evolved specialized
Type VII secretion systems (T7SS). The T7SSs were
* Correspondence: kkorotkov@uky.edu
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discovered based on attenuated strains of M. tuberculosis
deficient in EsxA (ESAT-6, early secreted antigenic target of 6 kDa) secretion and are commonly called ESAT
six (ESX) secretion systems [2–4]. In M. tuberculosis
there are five gene clusters, named ESX-1 to ESX-5, which
encode T7SS. Each gene cluster encodes a number of proteins that are either secreted or are building blocks for the
secretion apparatus. ESX-1 is responsible for secretion of
the important virulence factors EsxA and EsxB as well as
other virulence-associated proteins (e.g., EspB, EspF, EspJ)
that are secreted to the cell surface or extracellular milieu
based on recognition of a conserved C-terminal signal sequence on the secretion substrates [5–8]. These secreted
factors have been linked to mycobacterial virulence
through studies of the attenuated BCG strain of M. tuberculosis [2, 4, 9]; in non-pathogenic Mycobacterium smegmatis the orthologous ESX-1 system is involved in
conjugation [10, 11]. ESX-3 is critical for mycobacterial
survival due to its role in metal acquisition [12–14]. ESX5 is important for the secretion of many members of the
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PE/PPE family of proteins that also play a role in virulence
and cell wall integrity [15–17]. The functional role of
ESX-2 and ESX-4 is still unknown although ESX-4 appears to be the ancestral system from which the other
ESX systems have evolved [18].
All ESX gene clusters contain at least three or four ESX
conserved components (Ecc), named EccB, EccC, and
EccD, with EccE being present in all ESX systems with the
exception of ESX-4 [19]. Multiple copies of each core protein as well as other T7SS-associated proteins are present
in the core complex resulting in a large ~1500 kDa particle
[20]. The function of some core components is known, for
example, EccC is a member of the FtsK/SpoIIIE-like
ATPase family and provides the energy to transport proteins across the mycobacterial membrane(s) [21, 22]. EccD
contains an N-terminal cytoplasmic domain followed by
11 predicted transmembrane helices, and may form the
cytoplasmic membrane channel through which cargo proteins are secreted. The functions of EccB and EccE within
the secretion apparatus are less clear. These proteins both
have N-terminal transmembrane elements and large Cterminal regions predicted bioinformatically to be localized in the periplasm, but their molecular structures and
interacting partners remain unknown.
Understanding the T7SS architecture is critical for development of new antitubercular agents. Currently, no structural data is available for three of the four conserved
components EccB, EccD, and EccE. In this study we report
the molecular structures of the periplasmic domain of
EccB1 and the cytoplasmic domain of EccD1 from the
ESX-1 cluster. The structures reveal probable functional
surfaces of EccB1, and an unexpected dimerization by
EccD1. Here we describe these structures in detail and
how they might fit into the larger context of the T7SS.

Results and discussion
Structure of EccB1

M. tuberculosis EccB1 (Rv3869) is a 51 kDa protein containing a 40 amino acid (aa) N-terminal domain followed
by a single membrane-spanning helix and a ~400 aa Cterminal fold. EccB1 is annotated as a protein domain of
unknown function (DUF690) in the Pfam database [23]. In
order to gain further insight into the role of EccB1 within
the ESX machinery we determined the crystal structure of
the C-terminal domains of EccB1 from M. tuberculosis
(EccB1mt) to 1.7 Å resolution and of the orthologous protein (MSMEG_0060; EccB1ms) from the nonpathogenic
mycobacterial species M. smegmatis to 3.07 Å resolution.
Both EccB1 structures contain a single elongated fold in
the shape of a distorted propeller, which has an unanticipated quasi 2-fold symmetry (Fig. 1). A structural comparison of the EccB1mt and EccB1ms structures shows that
they are highly similar with an r.m.s.d. of 2.7 Å for the
superposition of 381 amino acids (Dali Z-score 42.2); there
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is considerable variability in the conformation of the extensive unstructured loops connecting secondary structure
elements which are, themselves, relatively well conserved
(Fig. 2) Five domains are present in the structures including a core domain flanked by two repeat domains on either
side. The central core domain consists of a 6 stranded βsheet with 5 strands (β7-β19-β18-β5-β6) arranged in antiparallel fashion with an additional strand (β21) parallel to
strand β6 on the periphery of the sheet; the sheet is further
stabilized by a disulfide bond between the two central
strands (β5 and β18) of the sheet formed between Cys150
and Cys345 (EccB1mt) and Cys152 and Cys347 (EccB1ms).
The four repeat domains each contain a 4 stranded β sheet
and two α helices (Fig. 1c). Repeat 1 (R1) (residues S74M124) and repeat 4 (R4) (residues G391-L445) are located
between the core domain and the N-terminal transmembrane region while repeat 2 (R2) (residues E185-P241) and
repeat 3 (R3) (residues V267-A320) are located on the
opposite side of the core domain distal to the transmembrane region. The interfaces between R1/R4 and R2/R3
domains are formed by hydrophobic residues on the Nterminal helices of each repeat that fold together with each
other and with hydrophobic residues from the proline rich
strands downstream of each repeat’s C-terminal helix. The
R2 and R3 domains also pack tightly with the core domain
via residues on their N-terminal helices as well as β sheet
residues. The tight packing involving residues on either
side of multiple repeat domains gives EccB1 a stable fold
with a continuous hydrophobic core and an elongated
pseudo-symmetrical shape.
A comparison of the repeat domains of EccB1mt gives
clues to the evolution of the protein. Pairwise sequence
alignments of the repeats shows that R2, R3, and R4 show
26, 33 and 27 % sequence identity, respectively, to R1. Pairwise alignments comparing R2–R4 to all other repeats
revealed that only R1 has significant identity to all 3 other
domains (Fig. 3). Therefore, it appears that R1 is the ancestral domain with R3 sharing more conserved features with
R1 than do either R2 or R4. EccB1ms contains a corresponding set of repeats in the same arrangement as seen in
EccB1mt: R1 (residues Q75–K127) is membrane proximal,
R4 (residues G392–L447), the central core domain, R2
(residues Q187–P243), and R3 (residues G267–E323)
which is distal to the membrane.
EccB1 does not bear significant sequence similarity to
any protein of known structure, and Dali searches using
the complete EccB1 structures revealed no proteins with
significant structural homology. However, Dali searches
using only EccB1mt repeat 1 (S74–P124) revealed weak
homology (r.m.s.d. 2.7 Å and Dali Z-score of 5.0) to the
N-terminal domain of PlyCB (PDB 4 F87, residues 14–70)
from streptococcal C1 bacteriophage [24]. Eight PlyCB
monomers assemble into a ring that associates with the
bacterial cell wall and facilitate phage egress by tethering
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Fig. 1 Overall structure and repeat domains of EccB1mt. a Domain organization of EccB1. The predicted transmembrane helix is indicated by a
shaded rectangle. The protein variants used for structure determination are shown as horizontal lines. b Overall structure of EccB1mt. The structure
is shown in cartoon representation with the central core domain in grey and repeats domains R1-R4 colored red, orange, green, and blue,
respectively. The disulfide bond between Cys150 and Cys345 is shown as yellow spheres. c Repeat domains R1–R4 have a common fold.
The isolated repeat domains are shown in the same orientation after superposition of repeats R2-R4 on repeat R1 using Chimera [52]

the degradative PlyCA subunit to the bacterial cell wall.
The structural similarity between the two proteins and a
common localization of both to bacterial cell envelope
structures is intriguing but no clues to EccB1 function are
apparent from our examination of PlyCB.

Structure of EccD1mt

EccD1mt (Rv3877) is a 54 kDa protein containing an
~110 amino acid (aa) N-terminal ubiquitin-like domain
followed by a 30 aa linker and 11 closely spaced transmembrane helices at its C-terminus. The ubiquitin-like
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Fig. 2 Superposition of EccB1mt and EccB1ms structures. a EccB1mt (grey) and EccB1ms (blue) were superimposed using Chimera. b Structure-based
sequence alignment of EccB1mt and EccB1ms prepared with ESPript (http://espript.ibcp.fr) [53] with numbering and secondary structure elements
derived from the EccB1mt sequence and structure
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Fig. 3 Structure-based sequence alignment of repeat domains of EccB1mt. Alignment was rendered using ESPript. Amino acid numbering above the
alignment refers to the repeat domain R1 sequence and indicated secondary structure elements are derived from the repeat domain R1 structure

domain of EccD1 classifies it as a member of the YukD
family within the Pfam database. Based on the characteristics of the transmembrane regions the N-terminal
portion of EccD1 is predicted to be localized in the
cytoplasm.
We grew crystals of the predicted cytoplasmic domain of
EccD1 from M. tuberculosis (cyto-EccD1mt) which diffracted to 1.88 Å. However, we could not obtain crystals of
Se-Met containing cyto-EccD1mt and attempts to perform
heavy atom soaks of fragile native crystals of cyto-EccD1mt
were unsuccessful. Therefore, we obtained crystals and
determined the structure of cyto-EccD1mt fused to maltose
binding protein (MBP) at a resolution of 2.20 Å by molecular replacement using an MBP structure (PDB ID 1ANF)
as the search model [25]. We subsequently solved the
1.88 Å cyto-EccD1mt structure by molecular replacement
using the EccD1mt segment of the MBP fusion protein. In
both structures EccD1mt residues 20–109 adopt an identical ubiquitin-like fold characterized by a β grasp motif and
an anti-parallel β sheet with strands in the order 2,1,5,3,4
(Fig. 4). The MBP fusion protein used as a crystallization
aid provides additional crystallization contacts, but it does
not perturb the fold of cyto-EccD1mt (Fig. 4d,e). The two
EccD1mt structures are superimposable with an r.m.s.d. of
0.7 Å over 90 residues and a Dali Z-score of 18.8.
Interestingly, the asymmetric unit of both crystal forms
contains two EccD1 molecules and in both crystal forms
the two EccD1 molecules are arranged as a head-to-tail
homodimer stabilized by an extensive interface. The interface is formed by interlocking side chains from β strands 1
and 2 and the N-terminal α-helix of both EccD1 molecules
(Fig. 4) and ~650 Å2 of each EccD1 molecule (13 % of the
total surface) is buried in the interface as calculated with
the PISA webserver [26]. The interaction is stabilized by 4
hydrogen bonds and a cluster of buried hydrophobic residues including Met1, Val54, and Val58 resulting in a solvation energy of −13.9 kcal/mol and a Complex Significance
Score of 1.0 calculated by the PISA server. The extensive
nature of the interface and its re-occurrence in both crystal
forms, with or without the MBP fusion, suggests that
EccD1 is a natural homodimer.
Dimerization of cyto-EccD1mt creates a wide openended groove bordered on two sides by the α1/β3 loops
(Fig. 5). The floor of the groove is formed by the two α

helices. Notably, the dimerization interface brings acidic
residues (Glu45, Asp49, Asp50, Glu57, Glu60, and Asp61)
from both chains into this groove. These acidic residues
are not offset by the presence of any basic residues in this
region thus they create a highly negative surface (Fig. 5b).
Putative function of EccB1 and EccD1

Mutations in EccB3 of the ESX-3 secretion system have
been shown to confer drug resistance in M. tuberculosis
[27]. The mutations found to confer resistance (Arg14Leu,
and Asn24His) occur in the small cytoplasmic domain
preceding the transmembrane element of EccB3, a region
not present in our EccB1 constructs which contain the soluble periplasmic domain. The fact that mutations in this
region confer drug resistance indicates an important function for this short region perhaps in mediating interactions with other cytoplasmically exposed components of
the T7SS. The elongated shape and continuous hydrophobic core of EccB1 suggest that it may serve a structural
role – perhaps forming part of a structure that spans the
inner and outer membrane components of the ESX secretion system. The structural similarities between PlyCB, the
viral cell wall binding protein complex, and EccB1 hints that
EccB1 may also bind elements of the peptidoglycan layer,
but there is not yet any experimental data to support this
idea. However, post-translational modification of secreted
bacterial proteins with O-linked polysaccharides has been
shown to be important for solubility or maintaining subcellular localization to the cell wall [28, 29]. EccB1 contains 24
putative glycosylation sites, as predicted by the NetOGlyc
webserver [30], and many of these are surface-exposed in
the EccB1 structures (including Ser143, Thr144, Ser351,
and Ser356). While this manuscript was under preparation,
the ATPase activity of EccB1 has been reported [31]. Further studies are needed to define the precise role of EccB1
in the context of a functional ESX-1 secretion complex.
The dimerization of the cytoplasmic domain of EccD1
raises interesting possibilities regarding the nature of the
transmembrane pore. Each EccD1 monomer has 11 transmembrane elements thus a dimer would have a total of 22
transmembrane elements. Each monomer may form an
independent pore resulting in a pair of closely associated
channels, or the transmembrane elements may comprise a
single, larger, transmembrane channel. The cytoplasmic
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Fig. 4 Structure of the cytoplasmic domain of EccD1mt. a Domain organization of EccD1. The predicted transmembrane helices 1–11 are indicated by
shaded rectangles. The protein construct used for crystallization is shown as a horizontal line. b cyto-EccD1mt monomer in cartoon representation
colored in rainbow colors from N-terminus (blue) to C-terminus (red). The secondary structure elements are labeled. c cyto-EccD1mt dimer in
cartoon representation with acidic residues shown in stick representation (see Fig. 5). d MBP-cyto-EccD1mt dimer in cartoon representation
with MBP moieties colored in grey and cyto-EccD1mt domains colored in blue and purple. e A close-up view of the MBP-cyto-EccD1mt dimer.
The orientation corresponds to panel c

domain itself is connected to the first transmembrane
element by a 30 amino acid linker that may facilitate
protein-protein interactions, either with the cytoplasmic

EccD1 domain or other components of the secretion system, or it may simply form an extended tether allowing
increased mobility of the ubiquitin-like domains.
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Fig. 5 Dimerization of cyto-EccD1mt creates a negatively charged groove. a cyto-EccD1mt dimer is shown in cartoon representation underneath a
semitransparent surface. Clustered acidic residues are shown in stick representation. b Electrostatic surface calculated using the APBS server [54]
with protonation states at pH 7.0 assigned by PROPKA [55]. The surface was colored +10 eV (blue) to −10 eV (red)

The negatively charged groove of the EccD1 dimer indicates that it should associate with a positively charged
partner(s). It may act to recruit other T7SS components
or secretion substrates with positively charged patches
into the system, or it may be part of a gating element
required to close the channel during periods of inactivity. The residues contributing to the negatively charged
groove are not conserved in EccD1 homologs from
other ESX systems indicating that they may serve a
system-specific role. Indeed, the ESX-1 locus encodes a
variety of secretion substrates not found in the paralogous M. tuberculosis ESX systems and thus it is likely
that the ESX-1 system has structural adaptations to enable the secretion of these substrates [6–8, 32]. As
more structures of ESX-1 components are determined
likely partners for interaction with the EccD1 dimer
may be revealed.

Conclusions
In summary, we have determined the structures of soluble domains of two integral, conserved components,
EccB1 and EccD1, of the ESX-1 secretion channel.
Given the importance of the ESX-1 secretion system to
mycobacterial virulence, our structures provide crucial
information about the molecular makeup of this important protein complex that will aid future drug development efforts.

Methods
Expression and purification of EccB1mt

A construct for expression of the periplasmic domain of
EccB1mt (residues 72–463) was designed based on predicted transmembrane helix using the TOPCONS server
[33], secondary structure prediction using the JPred4 server [34], and the sequence alignment of EccB1 orthologs
(Additional file 1: Figure S1). The DNA fragment was
PCR-amplified from M. tuberculosis H37Rv genomic
DNA using primers EccB1_F72_Nco 5′–CACCATGGGC
ACCAGCCTGTTCACCGACC and EccB1_RS463_Hind
5′–GCAAGCTTACAGCGTGTCGTGCTCGAGCAG,
and cloned into a modified pET-22b(+) vector (Novagen), which contains the Escherichia coli DsbA signal
sequence, a hexahistidine tag and a tobacco etch virus
(TEV) protease cleavage sequence.
EccB1mt was expressed in E. coli Rosetta2(DE3) strain
using LB media and 0.5 mM IPTG for induction. Cells
were harvested after 4 h incubation at 18 °C, resuspended in 20 mM Tris–HCl pH 8.0, 300 mM NaCl buffer, and lysed using microfluidizer (Avestin). EccB1mt
was purified via a Ni-NTA affinity column, incubated
with TEV protease to remove the hexahistidine tag, and
passed over a Ni-NTA column to remove uncleaved protein, and further purified by size exclusion chromatography using a Superdex 200 column (GE Healthcare).
Protein was flash-frozen using liquid nitrogen and stored
at −80 °C.
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Crystallization and structure determination of EccB1mt

Crystals were grown using the sitting drop vapor diffusion
method with precipitant containing 0.1 M Tris–HCl
pH 5.6, 15 % PEG2000 MME, 10 mM NiCl. Crystals were
transferred to crystallization solution supplemented with
20 % glycerol, or with 20 % glycerol and 0.5 NaI [35], and
flash-frozen in liquid nitrogen.
Data were collected at the 22-ID beamline at the Advance Photon Source, Argonne National Laboratory, and
processed using XDS [36] and HKL-3000 [37]. Iodide ion
positions were determined using SHELXD [38] as implemented in HKL-3000, and phases were calculated using

SHARP [39]. The model was built using Buccaneer [40]
and Coot [41], and refined by REFMAC5 [42] using TLS
groups defined by the TLSMD server [43]. The final structure includes residues 74–458.
Expression and purification of EccB1ms

The periplasmic domain (residues S73-G479) of the
MSMEG_0060 gene was PCR-amplified from M. smegmatis mc2155 genomic DNA with the gene-specific
primers MsEccB1.For. 5′-AACCTGTATTTCCAGAGT
AGTGACCAGCTGCTGGTGG and MsEccB1.Rev. 5′-T
TCGGGCTTTGTTAGCAGTTAGCCCTCCCCGCTCG

Table 1 Diffraction data collection and refinement statistics
EccB1mt
(PDB: 4KK7)

EccB1ms
(PDB: 5CYU)

cyto-EccD1mt
(PDB: 4KV2)

MBP-cyto-EccD1mt
(PDB: 4KV3)

Wavelength (Å)

1.0000

0.9789

1.0000

1.0000

Space group

P212121

P6122

P6522

P65

Data collection

Cell dimensions
a, b, c (Å)

31.70, 110.63, 110.51

74.41, 74.41, 280.60

46.72, 46.72, 279.02

125.68, 125.68, 124.49

α, β, γ, (°)

90, 90, 90

90, 90, 120

90, 90, 120

90, 90, 120

Resolution (Å)

49.48–1.68 (1.77–1.68)a

64.44–3.07 (3.15–3.07)

46.50–1.88 (1.98–1.88)

49.91–2.20 (2.32–2.20)

Rsym

0.053 (0.895)

0.103 (2.22)

0.106 (0.872)

0.105 (0.983)

CCb1/2

99.9 (50.0)

99.8 (56.0)

99.9 (88.1)

99.9 (82.9)

I/σI

14.2 (1.4)

13.7 (1.0)

20.6 (3.5)

17.7 (3.2)

Completeness (%)

94.1 (88.8)

92.9 (91.2)

100.0 (100.0)

100.0 (100.0)

Multiplicity

4.7 (3.0)

8.3 (7.7)

13.4 (13.9)

11.5 (11.5)

49.48–1.68

64.44–3.07

46.50–1.88

49.91–2.20

Refinement
Resolution (Å)
No. reflections (total/free)

42769/2118

8759/805

15842/794

56603/2862

Rwork/Rfree

0.177/0.214

0.241/0.297

0.188/0.236

0.163/0.205

2870

2650

1332

6970

No. atoms
Protein
Ligand/ion

18

0

0

46

Water

347

10

186

418

29.2

92.3

28.4

42.2

B-factors
Protein
Ligand/ion

30.2

Water

36.8

42.6

34.5

26.3
42.3

Wilson B

33.8

113.7

30.1

63.0

Bond lengths (Å)

0.009

0.008

0.010

0.008

Bond angles (°)

1.347

1.060

1.331

1.220

Favored

97.4

92.2

100.0

98.2

Outliers

0.0

0.0

0.0

0.2

R.m.s. deviations

c

Ramachandran distribution (%)

a

Values in parentheses are for the highest-resolution shell
b
Half-set correlation coefficient CC1/2 as defined in Karplus and Diederichs [56] and calculated using XSCALE [36] or Scala [57]
c
Calculated using the MolProbity server (http://molprobity.biochem.duke.edu) [58]
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and cloned into the pMAPLe4 expression vector [44],
which appends a TEV protease cleavable hexahistidine
tag to the N-terminus of the target protein, using the
Gibson ISO cloning method [45]. The sequence of
the expression clone was verified by DNA sequencing
(Genewiz, Piscataway, NJ).
Recombinant protein was overexpressed in E. coli
BL21(DE3) by inducing protein expression, of 1 L Terrific
broth cultures, at an OD600 of 1.0 with the addition of
IPTG to 0.5 mM. Cell growth was continued overnight at
18 °C. The following day the cells were harvested by centrifugation and resuspended in Buffer A (20 mM Tris,
pH 8.0, 300 mM NaCl, 10 % Glycerol) containing 10 mM
imidazole, 1 mM EDTA and Complete protease inhibitor
and lysed by sonication. The lysate was clarified by centrifugation (15,000 × g, 30 min, 4 °C) and the supernatant
was loaded on a Ni-NTA affinity column equilibrated in
Buffer A. After extensive washing the bound protein was
eluted with Buffer B (Buffer A containing 250 mM imidazole). The target protein was further purified by size exclusion chromatography using a Sephacryl S-100 column
(GE Healthcare) equilibrated in Buffer A.
Crystallization and structure determination of EccB1ms

Crystals of EccB1ms were grown using the hanging drop
vapor diffusion method by mixing protein at a 1:1 ratio of
protein to reservoir solution (14 % PEG 8000, 200 mM
NaCl, 100 mM phosphate-citrate pH 4.2). Crystals were
cryoprotected by a brief soak in reservoir solution containing 20 % propylene glycol. Data from a single crystal
was collected at beamline 24-ID-C at the Advanced Photon Source, Argonne National Laboratory. The data were
processed with XDS [36] and the structure solved by molecular replacement using the program Phaser [46] and a
homology model, prepared with the Phyre2 web server
[47], based on the structure of M. tuberculosis EccB1 (PDB
ID 4KK7). The structure was refined with BUSTER [48].
Expression and purification of cyto-EccD1mt

A construct for expression of the cytoplasmic domain of
EccD1mt (residues 21–109) was designed based on predicted ubiquitin-like domain using the HHpred server [49].
The DNA fragment was PCR-amplified from M. tuberculosis H37Rv genomic DNA using primers EccD1_F21_Nco
5′–CACCATGGCCACCACCCGGGTGACGATC and
EccD1_R109_SpeEcoR 5′–GGGAATTCACTAGTCATG
ACACCAGAGTCAGCAGTGAC, and cloned into a modified pET-Duet1 vector, which contains an N-terminal hexahistidine tag and TEV protease cleavage sequence. To
create a maltose-binding protein (MBP) fusion construct,
the same DNA fragment was cloned into a modified pET22b(+) vector, which contains an N-terminal hexahistidine
tag and TEV protease cleavage sequence followed by MBP
sequence. Both cyto-EccD1mt and MBP-cyto-EccD1mt
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proteins were expressed and purified as described for
EccB1mt. 5 mM maltose was included in the size-exclusion
buffer during purification of MBP-cyto-EccD1mt variant to
obtain ligand-bound MBP [50].
Crystallization and structure determination of MBP-cytoEccD1mt and cyto-EccD1mt

Crystals of cyto-EccD1mt were obtained by sitting drop
vapor diffusion method using 0.1 M Tris–HCl pH 8.5,
0.2 M Mg chloride, 30 % PEG4000 as precipitant. Crystals
were cryoprotected using crystallization solution supplemented with 10 % glycerol, and vitrified in liquid nitrogen.
Crystals grew as thin hexagonal plates and were mounted
in cryo-loops with 60° tilt (Mitigen) to avoid overlapping
reflections along the crystallographic c axis (Table 1).
Crystals of MBP-cyto-EccD1mt were obtained by sitting
drop vapor diffusion method using 0.1 M HEPES pH 7.5,
1.4 M Na citrate, and cryoprotected using crystallization
solution supplemented with 20 % glycerol.
Data were collected at the 22-ID beamline at the Advance Photon Source, Argonne National Laboratory,
and processed using XDS [36]. The structure of MBPcyto-EccD1mt was solved by molecular replacement using
Phaser [46] and an MBP structure as a search model (PDB
ID 1ANF) [25]. The electron density modification was performed using Parrot [51], and the model was extended
using Buccaneer and Coot. The fragment corresponding to
cyto-EccD1mt from the structure of MBP-cyto-EccD1mt was
used as a search model to solve the structure of cytoEccD1mt alone using Phaser. The structures were refined using REFMAC5 and TLS groups defined by the
TLSMD server.

Availability of supporting data
The structure factors and atomic coordinates have been
deposited in the Protein Data Bank under accession codes
4KK7 (EccB1mt), 5CYU (EccB1ms), 4KV2 (cyto-EccD1mt),
and 4KV3 (MBP-cyto-EccD1mt).
Additional file
Additional file 1: Figure S1. Sequence alignment of EccB orthologs
from M. tuberculosis H37Rv. The secondary structure elements of EccB1mt
are shown at the top of the alignment. The conserved Cys residues are
highlighted in blue. The vertical arrows indicate the beginning and end
of the EccB1mt expression construct which was used for crystallization.
(PDF 612 kb)
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